Amgen Inc.
Current price350.53USD
Fair value (est., median)312.01USD
UndervaluedFair valueOvervalued
+12.3% above fair valueWould need to fall ~11.0% to reach fair value.
Health Check
49.4
Overall / 100
Good (66+)Caution (40–65)Risk (<40)
Value37.7/100
Trades about 12.3% above its estimated fair value.
- Discount to fair value
- -12.3%
- Price to book
- 21.85×
- Fair-value confidence
- —
Future40.5/100
Modest growth of about 8% a year is expected.
- Forecast growth (rev.)
- 8%
- Revenue CAGR (18y)
- 5.2%
- Earnings CAGR (18y)
- 5.2%
Past78/100
High-quality returns — ROE around 89.1%.
- Return on equity
- 89.1%
- Net margin
- 21%
- Earnings CAGR (18y)
- 5.2%
- Profitable years
- 19/19
Health40/100
Carries meaningful debt relative to equity.
- Debt to equity
- 630.7%
- Net debt to equity
- 525.2%
- Cash covers total debt
- No
- Free cash flow
- Positive
Dividend50.9/100
Yields 2.71%, paying out 66.5% of earnings.
- Dividend yield
- 2.71%
- Payout ratio
- 66.5%
- Covered by free cash flow
- Yes
- Years paying
- 15
- Dividend growth
- —
Rewards
—
Risks
- Stretched balance sheet / elevated debt.
- Expensive on book (P/B 21.9×).
Scores are computed automatically from the real financial statements (Value from fair value; the rest from growth, profitability, balance sheet and dividends). A decision aid, not investment advice.
Price, corporate actions & news
Demo series
D — DividendS — Split▲ good · ▼ bad newstap a marker for details
Growth & profitability
Revenue, net income and margin.
RevenueNet incomeNet margin %tap a bar for figures
Key figures
| Metric | FY'21 | FY'22 | FY'23 | FY'24 | FY'25 |
|---|---|---|---|---|---|
| Revenue | 25.98B | 26.32B | 28.19B | 33.42B | 36.75B |
| Net Income | 5.89B | 6.55B | 6.72B | 4.09B | 7.71B |
| Net Margin | 22.7% | 24.9% | 23.8% | 12.2% | 21.0% |
| Operating Cash Flow | 9.26B | 9.72B | 8.47B | 11.49B | 9.96B |
| OCF Margin | 35.6% | 36.9% | 30.0% | 34.4% | 27.1% |
| Capital Expenditure | 880.00M | 936.00M | 1.11B | 1.10B | 1.86B |
| Free Cash Flow | 8.38B | 8.79B | 7.36B | 10.39B | 8.10B |
| FCF Margin | 32.3% | 33.4% | 26.1% | 31.1% | 22.0% |
| FCF Conversion | 142.2% | 134.1% | 109.6% | 254.1% | 105.0% |
| EPS (Diluted) | 10.92/sh | 12.14/sh | 12.45/sh | 7.58/sh | 14.29/sh |
| Dividend / Share | 7.44/sh | 7.77/sh | 8.44/sh | 8.95/sh | 9.49/sh |
Dividend return (if you buy today)if you buy today
Dividend yield2.71%
Dividend / share9.49 USD
If you invest
USD
Shares (≈)28
Est. annual income265.83 USD
At this rate, dividends alone return your capital in ~36.9 years.
Dividend history
Dividend / share & historical yield (USD).
Dividend / share yield %tap a bar for figures
Quarterly dividends & yield
Per-share dividends by quarter, full-year total, and yield on the year's average price · USD
| Year | Q1 | Q2 | Q3 | Q4 | Full year | Yield (avg) |
|---|---|---|---|---|---|---|
| 2026 | 2.52 | 2.52 | — | — | 5.04 | 1.5% |
| 2025 | 2.38 | 2.38 | 2.38 | 2.38 | 9.49 | 2.9% |
| 2024 | 2.25 | 2.25 | 2.25 | 2.25 | 8.95 | 2.9% |
| 2023 | 2.13 | 2.13 | 2.13 | 2.13 | 8.44 | 3.3% |
| 2022 | 1.94 | 1.94 | 1.94 | 1.94 | 7.77 | 3.1% |
| 2021 | 1.76 | 1.76 | 1.76 | 1.76 | 7.44 | 3.3% |
| 2020 | 1.60 | 1.60 | 1.60 | 1.60 | 6.96 | 3.0% |
| 2019 | 1.45 | 1.45 | 1.45 | 1.45 | 6.50 | 3.2% |
| 2018 | — | — | — | — | 6.50 | 3.3% |
| 2017 | — | — | — | — | 6.23 | 3.6% |
| 2016 | — | — | — | — | 5.55 | 3.4% |
| 2015 | — | — | — | — | 4.44 | 2.9% |
| 2014 | — | — | — | — | 3.43 | 2.4% |
| 2013 | — | — | — | — | 2.62 | 2.3% |
| 2012 | — | — | — | — | 2.07 | 2.5% |
| 2011 | — | — | — | — | 0.93 | 1.5% |
| 2010 | — | — | — | — | — | — |
| 2009 | — | — | — | — | — | — |
| 2008 | — | — | — | — | — | — |
| 2007 | — | — | — | — | — | — |
Corporate actions
DCash Dividend
2.52 USD /sh2026-05-15
DCash Dividend
2.52 USD /sh2026-02-13
DCash Dividend
2.38 USD /sh2025-11-21
DCash Dividend
2.38 USD /sh2025-08-22
DCash Dividend
2.38 USD /sh2025-05-16
DCash Dividend
2.38 USD /sh2025-02-14
DCash Dividend
2.25 USD /sh2024-11-18
DCash Dividend
2.25 USD /sh2024-08-16
DCash Dividend
2.25 USD /sh2024-05-16
DCash Dividend
2.25 USD /sh2024-02-15
Valuation breakdown
Fair value = median of the applicable methods (DCF، DDM، Graham).
Discounted Cash Flow
Tap to adjust assumptions
382.91 USD
Dividend Discount Model
Tap to adjust assumptions
241.12 USD
Graham Number
Tap to adjust assumptions
69.42 USD
Residual Income (justified P/B)
Excluded — needs positive book value
N/A
Earnings Power Value
Excluded — non-positive normalized earnings
N/A
Fair Value (median)312.01 USD
▸ Show assumptions▾ Assumptions
- Effective discount rate
- 7.06%
- CAPM cost of equity
- 7.62%
- Risk-free rate
- 4.50%
- Equity risk premium
- 7.50%
- DCF growth (stage 1)
- 8.00%
- DCF terminal growth
- 3.00%
- DCF forecast years
- 10
- DDM dividend growth
- 3.00%
Tune these per company in the Hajras Odoo backend; values recompute automatically.
Wealth simulator
What if you'd invested in Amgen Inc. regularly?
Starting year
- Invested
- 1K/yr · 43K total(1984 → today · 43 yrs)
- your value today is
- 12M USD
- Total return
- +27774.3%(+5304.0% Dividends · +22470.2% Capital gain)
- Annualised (IRR)
- +20.8%
Invested43KUSD
Dividends2.3MUSD
Capital gain9.7MUSD
InvestedCapital gainDividendstap a bar for figures
Community Notes0
No notes yet. Be the first to share a thesis.